doi:10.1152/ajpendo.00104.2002 You might find this additional information useful... This article cites 18 articles, 13 of which you can access free at
Thiazolidinediones are insulin-sensitizing compounds that reduce plasma glucose and improve the lipi...
AIM: We investigated whether rosiglitazone protects beta-cells from glucolipotoxicity directly. MET...
Thiazolidinediones (TZDs) improve glycemic control and insulin sensitivity in patients with type 2 d...
Aims/hypothesis Rosiglitazone and metformin are two oral antihyperglycaemic drugs used to treat type...
AIMS/HYPOTHESIS: In addition to the improvement in insulin sensitivity, it has been shown that thiaz...
Type 2 diabetes mellitus is characterised by impaired insulin secretion, diminished peripheral insul...
AIMS: We examined the effect of rosiglitazone on insulin sensitivity, abdominal fat and mid-thigh in...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Objective: To investigate the effects of rosiglitazone (RSG) on insulin sensitivity and regional adi...
A wealth of recent evidence implicates increasing obesity levels in the rising global epidemic of ty...
Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve i...
Background Rosiglitazone not only improves insulin-sensitivity, but also exerts anti-inflammatory ef...
ABSTRACT: Background Rosiglitazone not only improves insulin-sensitivity, but also exerts anti-infla...
Copyright © 2015 Metin Guclu et al. This is an open access article distributed under the Creative Co...
OBJECTIVE-ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial monotherapy with ro...
Thiazolidinediones are insulin-sensitizing compounds that reduce plasma glucose and improve the lipi...
AIM: We investigated whether rosiglitazone protects beta-cells from glucolipotoxicity directly. MET...
Thiazolidinediones (TZDs) improve glycemic control and insulin sensitivity in patients with type 2 d...
Aims/hypothesis Rosiglitazone and metformin are two oral antihyperglycaemic drugs used to treat type...
AIMS/HYPOTHESIS: In addition to the improvement in insulin sensitivity, it has been shown that thiaz...
Type 2 diabetes mellitus is characterised by impaired insulin secretion, diminished peripheral insul...
AIMS: We examined the effect of rosiglitazone on insulin sensitivity, abdominal fat and mid-thigh in...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Objective: To investigate the effects of rosiglitazone (RSG) on insulin sensitivity and regional adi...
A wealth of recent evidence implicates increasing obesity levels in the rising global epidemic of ty...
Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve i...
Background Rosiglitazone not only improves insulin-sensitivity, but also exerts anti-inflammatory ef...
ABSTRACT: Background Rosiglitazone not only improves insulin-sensitivity, but also exerts anti-infla...
Copyright © 2015 Metin Guclu et al. This is an open access article distributed under the Creative Co...
OBJECTIVE-ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial monotherapy with ro...
Thiazolidinediones are insulin-sensitizing compounds that reduce plasma glucose and improve the lipi...
AIM: We investigated whether rosiglitazone protects beta-cells from glucolipotoxicity directly. MET...
Thiazolidinediones (TZDs) improve glycemic control and insulin sensitivity in patients with type 2 d...